Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

74.90 1.65 −2.16%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 6 6 7
ROE
4.82% 4.50% 3.71% 2.94%
ROA
3.38% 3.17% 2.62% 2.06%
ROIC
3.56% 3.38% 2.94% 2.38%
Return on Tangible Assets
13.02% 11.99% 9.78% 7.84%
Average Days of Receivables
69.49 68.85 68.99 70.57
Free Cash Flow per Share
2.81 3.27 3.28 3.28
Free Cash Flow
1,385.00 1,613.00 1,596.00 1,594.00
Other line items

Show all line items

Columns are period end dates